Gender-specific correlation of platelet ionized magnesium and serum low-density-lipoprotein cholesterol concentrations in apparently healthy subjects

Journal of Laboratory and Clinical Medicine

Volumn 129, Issue 1, 1997, Pages 89-96

  Niemela, Julie E ^b   Csako, Gyorgy ^b   Bui, Minh N ^b   Elin, Ronald J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030720957     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(97)90165-7     Document Type: Article

References (68)

1. Rayssiguier Y. New data on magnesium and lipid interrelationships in pathogenesis of vascular disease in magnesium deficiency. In: Halpern M, Durlach J, editors. Magnesium deficiency: physiopathology and treatment implications. New York: Karger, 1985:122-31.
2. Niemela J, Snader B, Elin R. Determination of ionized magnesium in platelets and correlation with selected variables. Clin Chem 1996;42:744-8.
3. Ortega A, Mas-Oliva J. Direct regulatory effect of cholesterol on the calmodulin stimulated calcium pump of cardiac sarcolemma. Biochim Biophys Res Commun 1986;139:868-74.
4. Kutryk M, Pierce G. Stimulation of sodium-calcium exchange by cholesterol incorporation into isolated cardiac sarcolemmal vesicles. J Biol Chem 1988;263:13167-72.
5. Liu K, Pierce G. The modulation of ion movements by cholesterol. In: Bkaily G, editor. Membrane physiopathology. Boston: Kluwer Academic Publishers, 1994:291-317.
6. Abeywardena M, McMurchie E, Russell G, Sawyer W, Charnick J. Response of rat heart membranes and associated ion-transporting ATPases to dietary lipids. Biochim Biophys Acta 1984;776:48-59.
7. Kutscherskij E, Gunther J, Mehley E. K-p-nitrophenylphosphatase activity, Na and K content, Na permeability and membrane lipid composition in rabbit myocardium after cholesterol rich diet. Experientia 1984;40:812-5.
8. Gunther J, Kutscherskij E. Changes in sarcolemmal K+-pnitrophenylphosphatase activity induced by atherogenic cholesterol-rapeseed oil diet in rabbit myocardium. Adv Myocardiol 1982;3:329-34.
9. Cooper R. Influence of membrane fluidity and cell function in human red blood cells. J Supramol Struct 1978;8:413-30.
10. Sevanian A, Hodis H, Hwang J, McLeod L, Peterson H. Characterization of endothelial cell injury by cholesterol oxidation products found in oxidized LDL. J Lipid Res 1995; 36:1971-86.
11. Liu K. Effects of oxidative modification of cholesterol in isolated low density lipoproteins on cultured smooth muscle cells. Mol Cell Biochem 1991;108:49-56.
12. Liu K, Maddaford T, Ramjiawan B, Kutryk M, Pierce G. Effects of cholesterol oxidase on cultured vascular smooth muscle cells. Mol Cell Biochem 1991;108:39-48.
13. Cronin R, Ferguson E, Shannon W, Knochel J. Skeletal muscle injury after magnesium depletion in the dog. Am J Physiol 1982;243:F113-20.
14. Robeson B, Martin W, Freidman M. A biochemical and ultrastructural study of skeletal muscle from rats fed a magnesium-deficient diet. J Nutr 1980;110:2078-84.
15. Rayssiguier Y, Gueux E, Bussiere L, Durlach J, Mazur A. Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J Am Coll Nutr 1993;12:133-7.
16. Rock E, Astier C, Lab C, et al. Dietary magnesium deficiency in rats enhances free radical production in skeletal muscle. J Nutr 1994;125:1205-10.
17. Tongyai S, Rayssiguier Y, Motta C, Gueux E, Maurois P, Heaton F. Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. Am J Physiol 1989;257:C270-6.
18. Okada K, Ishikawa S, Saito T. Cellular mechanisms of vasopressin and endothelin to mobilize [Mg2+]i in vascular smooth muscle cells. Am J Physiol 1992;263:C873-8,
19. Bond M, Vadasz G, Somlyo A. Subcellular calcium and magnesium mobilization in rat liver stimulated in vivo with vasopressin and glucagon. J Biol Chem 1987;262:15630-6.
20. Hwang DL, Yen CF, Nadler JL. Insulin increases intracellular magnesium transport in human platelets. J Clin Endocrinol Metab 1993;76:549-53.
21. Touyz RM. The effect of angiotensin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension. J Hypertens 1993;11:551-8.
22. Touyz R, Mine F. Alterations in intracellular cations and cell membrane ATPase activity in patients with malignant hypertension. J Hypertens 1995;13:867-74.
23. Seelig M. Interrelationships of magnesium and estrogen in cardiovascular and bone disorders, eclampsia, migraine and premenstrual syndrome. J Am Coll Nutr 1993;12:442-58.
24. Bui M, Sack M, Moutsatsos G, et al. Autoantibody titers to oxidatively modified low-density lipoprotein in patients with coronary atherosclerosis. Am Heart J 1996;131:663-7.
25. Spector A, Yorek M. Membrane lipid composition and cellular function. J Lipid Res 1985;1985;1015-35.
26. Colman R. The role of platelets in the genesis of ischemia. Ann NY Acad Sci 1982;382:190-203.
27. Mehta J, Chen L. Reversal by high-density lipoprotein of the effect of oxidized low-density lipoprotein on nitric oxide synthase protein expression in human platelets. J Lab Clin Med 1996;127:287-95.
28. Lange Y, Ramos B. Analysis of the distribution of cholesterol in the intact cell. J Biol Chem 1983;258:15130-4.
29. Bing R, Heagerty A, Thurston H, Swales J. Ion transport in hypertension: are changes in the cell membrane responsible? Clin Sci 1986;71:225-30.
30. Kochhar N, Kaul D. Molecular link between membrane cholesterol and Na+/H+ exchange within human platelets. FEBS Lett 1992;299:19-22.
31. Seelig M. Increased need for magnesium with the use of combined oestrogen and calcium for osteoporosis treatment. Magn Res 1990;3:197-215,
32. Seelig M, Heggtveit H. Magnesium interrelationships in ischemic heart disease: a review. Am J Clin Nutr 1974;27:59-79.
33. Seelig M, Haddy F. Magnesium and the arteries: I. Effects of magnesium deficiency on arteries and on retention of sodium, potassium, and calcium. In: Cantin M, Seelig M, editors. Magnesium in health and disease. New York: Spectrum, 1980:605-38.
34. Vitale J, Hellerstein E, Hegsted D, Nakamura M, Farbman A. Studies on the interrelationships between dietary magnesium and calcium in atherogenesis and renal lesions. Am J Clin Nutr 1959;7:13-22.
35. Bunce G, Chiemchaisri Y, Philips P. The mineral requirements of the dog. IV. Effect of certain dietary and physiologic factors upon the magnesium defeciency syndrome. J Nutr 1962;76:23-9.
36. Sos J, Gati T, Kemeny T, Rigo J. Infarctoid cardiac lesions induced by dietetic factors in the dog. Acta Med Acad Sci Hung 1964;20:1-8.
37. Vitale J, White P, Nakamura M, Hegsted D. Effect of feeding an atherogenic diet on magnesium requirement. Fed Proc 1957;16:400-1.
38. Vitale JJ, White PL, Nakamura M, Hegsted DM, Zamcheck N, Hellerstein EE. Interrelationships between experimental hypercholesteremia, magnesium requirement, and experimental atherosclerosis. J Exp Med 1957;106:757-66.
39. Szelenyi I, Rigo J, Ahmed B, Sos J. The role of magnesium in blood coagulation. Thromb Diath Hemorrh 1972;18:626-33.
40. 4. Pathol Biol 1972;20:751-6.
41. Lacoste L, Lam J, Hung J, Letchacovski G, Solymoss C, Waters D. Hyperlipidemia and coronary artery disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995;92:3172-7.
42. Nadler J, Malayan S, Luong H, Shaw S, Natarajan R, Rude R. Intracellular free magnesium defeciency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care 1992;15:835-41.
43. Chait A. Methods for assessing lipid and lipoprotein oxidation. Curr Opin Lipidol 1992;3:389-94.
44. Steinberg D. Modified forms of low density lipoprotein and atherosclerosis. J Intern Med 1993;233:227-32.
45. Craig W. Autoantibodies against low density lipoprotein: a review of clinical findings and assay methodology. J Clin Lab Anal 1995;9:70-4.
46. Carvallho A, Colman R, Lees R. Platelet function in hyperlipoproteinemia. N Engl J Med 1974;290:434-8.
47. Hassal D, Owen J, Bruckdorfer K. The aggregation of isolated human platelets in the presence of lipoproteins and prostacyclin. Biochem J 1983;216:43-9.
48. Rock E, Astier C, Lab C, et al. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magn Res 1995;8:237-42.
49. Radi R, Beckman J, Bush K, Freeman B. Peroxynitriteinduced lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991;288: 481-7.
50. Weglicki W, Philips T, Freedman A, Cassidy M, Dickens B. Magnesium deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992; 110:169-73.
51. Rayssiguier Y, Gueux E, Bussiere L, Durlach J, Mazur A. Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J Am Coll Nutr 1993;12:133-7.
52. Rayssiguier Y, Mazur A, Gueux E, Rock E. Magnesium deficiency affects lipid metabolism and atherosclerosis processes by mechanism involving inflammation and oxidative stress. Magn Res 1994;7:46-7.
53. Aviram M, Furham B, Keidar S, et al. Platelet-modified low density lipoprotein induces macrophage cholesterol accumulation and platelet activation. J Clin Chem Clin Biochem 1989;27:3-12.
54. Gutteridge J, Richmond R, Halliwell B. Oxygen free-radicals and lipid peroxidation: inhibition by the protein caeruloplasmin. FEBS Lett 1980;112:269-72.
55. Ehrenwald E, Fox P. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells. J Clin Invest 1996;97:884-90.
56. Sissan M, Menon V, Leelamma S. Effects of low-dose oral contraceptive oestrogen and progestin on lipid peroxidation in rats. J Int Med Res 1995;23:272-8.
57. Bagatell C, Knopp R, Rivier J, Bremner W. Physiological levels of estradiol stimulate plasma high density lipoprotein-2 cholesterol levels in normal men. J Clin Endocrinol Metab 1994;78:855-61.
58. Jacobs D, Mebane I, Bangdiwala S, Criqui M, Tyroler H. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32-47.
59. Gordon R, Castelli W, Hortland M. High density lipoprotein as a protective factor against coronary artery disease. Am J Med 1977;62:707-14.
60. Tonolo G, Ciccarese M, Brizzi P, et al. Cyclical variation of plasma lipids, apolipoproteins, and lipoprotein(a) during menstrual cycle of normal women. Am J Physiol 1995;269: E1101-5.
61. Sack M, Rader D, Cannon III R. Oestrogen and inhibition of low-density lipoproteins in postmenopausal women. Lancet 1994;343:269-70.
62. Seelig M. Magnesium deficiency in the pathogenesis of disease. New York: Plenum, 1980.
63. Best F, Pickles V. Effects of treatment with oestradiol and progesterone on the calcium and magnesium content of the guinea pig and rabbit myometrium, and on its sensitivity to stimulants. J Endocrinol 1965;32:121-2.
64. Whitfield C, Tidball R. Estrogen effect on skeletal muscle and degenerative signs of experimental Mg defeciency. Fed Proc 1968;27:498.
65. Gozan K, Charnot Y. Influence of synthetic estro-progestational agents on tissue levels of certain inorganic molecules (Ca, Mg): rat study. CR Seances Soc Biol Fil 1973;167:484-7.
66. Charnot Y, Gozan K, Peres G. Oestro-progestifs et metabolimes du calcium, du magnesium et du silicium. Ann Endocrinol 1974;35:329-35.
67. Goldsmith N. Physiologic relationship between magnesium and the female reproductive apparatus. Serum magnesium variations in normal subjects: the effect of estrogen on magnesium distribution. In: Durlach J, editor. Proceedings of the First International Symposium on Magnesium. Vittel, France: 1971:439-58.
68. Lowenstein F. Oral contraceptives and cardiovascular disease. Lancet 1966;2:1365.